Elan Corporation

Pharmaceutical company

5/16/2008 12:19 ET

Site Map | Contact Us | Search:

  • NYSE | ELN | 27.15 | -0.27  (20 minute delay)
   

 

 


               These are large files please allow sufficient time to download

Feature:

  • WEBCAST REPLAY: Elan Presents at Morgan Stanley Global Healthcare Unplugged Conference...more
  • WEBCAST REPLAY: First-Quarter 2008 Financial Results...more
  • Elan Reports First-Quarter 2008 Financial Results...more                     

Marketed Products
in the U.S.

  • TYSABRI®
    (natalizumab)
  • PRIALT®
    (ziconotide intrathecal infusion) 
  • Azactam®
    (aztreonam for injection, USP)
  • Maxipime®
    (cefepime hydrochloride) for injection                      

Copyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use